Half-year report · HY
4888.TEDINET S100WZFR
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥200m | 2025-04-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥961m | 2024-04-01 → 2025-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥169m | 2024-04-01 → 2024-09-30 | Standalone | Net sales |
| Operating income | −¥299m | 2025-04-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | −¥269m | 2024-04-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | −¥306m | 2025-04-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥138m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥267m | 2024-04-01 → 2024-09-30 | Standalone | Ordinary income |
| Profit before tax | −¥306m | 2025-04-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥267m | 2024-04-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | −¥308m | 2025-04-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | −¥141m | 2024-04-01 → 2025-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥269m | 2024-04-01 → 2024-09-30 | Standalone | Profit loss |
| Total assets | ¥4.9bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥5.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥5.2bn | at 2024-09-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.0bn | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥2.2bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.9bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥3.2bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.1bn | at 2024-09-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.2bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.8bn | at 2025-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.2bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2024-03-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥321m | 2025-04-01 → 2025-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥140m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥546m | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥9m | 2025-04-01 → 2025-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥288m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥88m | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | −¥79m | 2025-04-01 → 2025-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥721m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥866m | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-9.05 | 2025-04-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.22 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.21 | 2024-04-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 58.9% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.2% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.2% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 34,034,100 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 34,034,100 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 34,034,100 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 411
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding dividend (text) | Prior1InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc type1 semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | InterimDuration_NonConsolidatedMember | Original text (Japanese)当社の事業セグメントは、医薬品開発事業のみの単一セグメントであり、セグメント情報の記載を省略しております。 | |
| Notes revenue recognition semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Other information financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |